IQVIA Holdings Research and Development Expenses 2011-2024 | IQV
IQVIA Holdings annual/quarterly research and development expenses history and growth rate from 2011 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- IQVIA Holdings research and development expenses for the quarter ending March 31, 2024 were $M, a NAN% increase year-over-year.
- IQVIA Holdings research and development expenses for the twelve months ending March 31, 2024 were $0M, a NAN% increase year-over-year.
- IQVIA Holdings annual research and development expenses for 2023 were $0B, a NAN% decline from 2022.
- IQVIA Holdings annual research and development expenses for 2022 were $0B, a NAN% decline from 2021.
- IQVIA Holdings annual research and development expenses for 2021 were $0B, a NAN% decline from 2020.
| IQVIA Holdings Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| 2014 | $ |
| 2013 | $ |
| 2012 | $ |
| 2011 | $ |
| 2010 | $ |
| IQVIA Holdings Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | $0 |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $41.731B | $14.984B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $225.480B | 27.32 |
| Intuitive Surgical (ISRG) | United States | $135.098B | 81.39 |
| Edwards Lifesciences (EW) | United States | $51.040B | 33.22 |
| DexCom (DXCM) | United States | $49.691B | 75.27 |
| IDEXX Laboratories (IDXX) | United States | $41.543B | 48.69 |
| Alcon (ALC) | Switzerland | $39.902B | 28.59 |
| STERIS (STE) | Ireland | $22.980B | 26.85 |
| Waters (WAT) | United States | $20.719B | 30.45 |
| Hologic (HOLX) | United States | $17.636B | 19.73 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.555B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.711B | 14.84 |
| ShockWave Medical (SWAV) | United States | $12.404B | 77.19 |
| Sysmex ADR (SSMXY) | Japan | $10.586B | 33.20 |
| Teleflex (TFX) | United States | $9.765B | 15.20 |
| Globus Medical (GMED) | United States | $8.630B | 25.30 |
| Penumbra (PEN) | United States | $7.938B | 90.21 |
| Masimo (MASI) | United States | $6.166B | 35.52 |
| Glaukos (GKOS) | United States | $5.458B | 0.00 |
| TransMedics (TMDX) | United States | $4.349B | 412.62 |
| Integer Holdings (ITGR) | United States | $3.776B | 22.81 |
| LivaNova (LIVN) | United Kingdom | $3.311B | 19.66 |
| PROCEPT BioRobotics (PRCT) | United States | $3.265B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.865B | 19.66 |
| Tandem Diabetes Care (TNDM) | United States | $2.837B | 0.00 |
| Inari Medical (NARI) | United States | $2.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.582B | 21.84 |
| RxSight (RXST) | United States | $2.175B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.065B | 9.01 |
| Veracyte (VCYT) | United States | $1.720B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.558B | 0.00 |
| Artivion (AORT) | United States | $0.967B | 92.80 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.913B | 17.75 |
| OPKO Health (OPK) | United States | $0.878B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.817B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.742B | 0.00 |
| Paragon 28 (FNA) | United States | $0.673B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.628B | 21.31 |
| SiBone (SIBN) | United States | $0.618B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.564B | 0.00 |
| IRadimed (IRMD) | United States | $0.538B | 30.11 |
| Pacific Biosciences Of California (PACB) | United States | $0.526B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.395B | 0.00 |
| Nevro (NVRO) | United States | $0.374B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.329B | 11.24 |
| Treace Medical Concepts (TMCI) | United States | $0.281B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.270B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AxoGen (AXGN) | United States | $0.253B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.245B | 0.00 |
| NeuroPace (NPCE) | United States | $0.245B | 0.00 |
| 908 Devices (MASS) | United States | $0.226B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.183B | 0.00 |
| CVRx (CVRX) | United States | $0.166B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.163B | 8.27 |
| ClearPoint Neuro (CLPT) | United States | $0.160B | 0.00 |
| Accuray (ARAY) | United States | $0.157B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.150B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.103B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.096B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.089B | 18.62 |
| Neuronetics (STIM) | United States | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.063B | 0.00 |
| Envoy Medical (COCH) | United States | $0.061B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.060B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| InspireMD (NSPR) | Israel | $0.056B | 0.00 |
| DarioHealth (DRIO) | United States | $0.052B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.050B | 0.00 |
| Vasomedical (VASO) | United States | $0.050B | 9.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| LENSAR (LNSR) | United States | $0.044B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.042B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.027B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.024B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |